Obstetrics/Gynecology General
RSSArticles
-
Combined Oral Contraceptives Can Help Some with Premenstrual Dysphoric Disorder
Reproductive health patients often describe having unpleasant symptoms related to their menstrual cycle. Premenstrual syndrome, for example, refers to any mood symptoms in the days or weeks before their period begins.
-
U.S. Supreme Court’s Decision on Emergency Abortions Raises More Questions than Answers
The big question for OB/GYNs, emergency department (ED) physicians, and the reproductive healthcare community is whether the U.S. Supreme Court’s decision on June 27, 2024, in the case of Idaho and Moyle v. United States, will change emergency care for pregnant women in the United States.
-
Study Shows that Family Planning Needs of Hispanics Vary According to Acculturation
New research of Hispanic women surveyed at a public hospital in a New York City suburb shows that a large proportion — nearly three in five — were unaware of the Dobbs Supreme Court decision that overturned Roe v. Wade.
-
Study Suggests Need for Update in LARC Counseling About Acne
Investigators evaluated adolescent and young adult study participants seeking progestin-only long-acting reversible contraception (LARC) and found there was a risk of the contraceptive worsening acne.
-
Study: Small Decrease in Applicants to OB/GYN Residency Programs in Abortion-Ban States
Researchers looked at the impact of the overturn of Roe v. Wade on OB/GYN residency programs in the first year after the U.S. Supreme Court gave states the power to pass abortion bans with its decision in Dobbs v. Jackson Women’s Health Organization. They found there was a small but significant decrease in the number of applications to states with stricter abortion laws from 2022 to 2023.
-
What Did Supreme Court Justices Say About EMTALA and Abortion?
By the end of June, the U.S. Supreme Court will decide on whether Idaho and other states can require hospitals — through criminal laws — to turn away pregnant women experiencing a major health crisis when the best treatment for them is an abortion to end their pregnancy. Idaho presented a case that their state law preempts the Emergency Medical Treatment and Active Labor Act (EMTALA), and the federal government argued that EMTALA and the mission of protecting patients’ health and lives takes precedence.
-
EMTALA Has Protected Pregnant Patients for Three Decades — Now That Could Be at Risk
Health-preserving emergency care for pregnant women could be up to each physician’s conscience and risk-taking ability after the U.S. Supreme Court debates whether the state of Idaho is exempt from providing emergency abortion care to women who may lose their uteruses or kidneys or suffer other major health problems with delayed abortion care.
-
U.S. Supreme Court Unanimously Rejected Lawsuit Challenging FDA’s Mifepristone Decisions
Reproductive healthcare and abortion providers can exhale in relief — however briefly — because a unanimous U.S. Supreme Court decision maintains telehealth access to mifepristone, an abortion drug, in the United States.
-
Furosemide for the Management of Postpartum Hypertension
Current evidence does not support the effectiveness of furosemide in reducing the mean arterial pressure within 24 hours before discharge from delivery hospitalization or before starting antihypertensive medications, compared to a placebo.
-
What Do Clinicians Think About the American Cancer Society Cervical Cancer Screening Guidelines?
In this study of provider attitudes toward the American Cancer Society 2020 cervical cancer screening guidelines that recommend deferring screening until age 25 years and using human papilloma virus alone as the primary screening, most providers had not adopted the guidelines and were waiting for endorsement by other professional societies, such as the American College of Obstetricians and Gynecologists and the American Society for Colposcopy and Cervical Pathology.